David Shaw’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-29,190
Closed -$374K 4598
2025
Q1
$374K Sell
29,190
-2,247
-7% -$36.1K ﹤0.01% 3656
2024
Q4
$555K Buy
31,437
+4,354
+16% +$82.6K ﹤0.01% 3548
2024
Q3
$619K Sell
27,083
-9,282
-26% -$210K ﹤0.01% 3585
2024
Q2
$835K Buy
+36,365
New +$1.12M ﹤0.01% 3297
2024
Q1
Sell
-20,452
Closed -$809K 4606
2023
Q4
$809K Buy
+20,452
New +$856K ﹤0.01% 3276
2022
Q2
Sell
-5,329
Closed -$211K 5628
2022
Q1
$211K Buy
+5,329
New +$209K ﹤0.01% 4836
2020
Q3
Sell
-5,801
Closed -$338K 4049
2020
Q2
$338K Sell
5,801
-300
-5% -$15.8K ﹤0.01% 3576
2020
Q1
$277K Sell
6,101
-309
-5% -$18.6K ﹤0.01% 3511
2019
Q4
$423K Sell
6,410
-602
-9% -$36.8K ﹤0.01% 3478
2019
Q3
$405K Buy
7,012
+3,055
+77% +$189K ﹤0.01% 3310
2019
Q2
$228K Buy
+3,957
New +$183K ﹤0.01% 3419

Other funds holding NRC

David Shaw's NRC Position: Q2 2025 in Review

David Shaw sold out of NRC Health Common Stock (NRC) in Q2 2025, closing a stake of 29,190 shares — an estimated $374K sold.

David Shaw first reported a position in NRC in Q2 2019 and held it in 11 quarters. The position peaked at $835K in Q2 2024. 126 funds tracked by Wall St. Rank hold NRC as of Q2 2025.

  • David Shaw reported no remaining NRC Health Common Stock position as of Q2 2025 after selling out during the quarter.
  • David Shaw sold 29,190 NRC Health Common Stock shares in Q2 2025, an estimated $374K.
  • David Shaw first reported a position in NRC Health Common Stock in Q2 2019 and held it in 11 quarters.
  • David Shaw's NRC Health Common Stock position peaked at $835K in Q2 2024.
  • 126 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2025.

Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.